DOGLIOTTI, Luigi
DOGLIOTTI, Luigi
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
2010-01-01 Mele, Teresa; Generali, Daniele; Fox, Stephen; Brizzi, Maria Pia; Bersiga, Alessandra; Milani, Manuela; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Volante, Marco; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian; Berruti, Alfredo
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network
2009-01-01 Brizzi, Maria P.; Berruti, Alfredo; Ferrero, Anna; Milanesi, Enrica; Volante, Marco; Castiglione, Federico; Birocco, Nadia; Bombaci, Sebastiano; Perroni, Davide; Ferretti, Benedetta; Alabiso, Oscar; Ciuffreda, Libero; Bertetto, Oscar; Papotti, Mauro; Dogliotti, Luigi
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]]
2016-01-01 Arpino, Grazia; Generali, Daniele; Sapino, Anna; Del Mastro, Lucia; Frassoldati, Antonio; de Laurentiis, Michelino; Pronzato, Paolo; Mustacchi, Giorgio; Cazzaniga, Marina; De Placido, Sabino; Conte, Pierfranco; Cappelletti, Mariarosa; Zanoni, Vanessa; Antonelli, Andrea; Martinotti, Mario; Puglisi, Fabio; Berruti, Alfredo; Bottini, Alberto; Dogliotti, Luigi
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)
2015-01-01 Amoroso, Vito; Generali, Daniele; Buchholz, Thomas; Cristofanilli, Massimo; Pedersini, Rebecca; Curigliano, Giuseppe; Daidone, Maria Grazia; Di Cosimo, Serena; Dowsett, Mitchell; Fox, Stephen; Harris, Adrian L.; Makris, Andreas; Vassalli, Lucia; Ravelli, Andrea; Cappelletti, Maria Rosa; Hatzis, Christos; Hudis, Clifford A.; Pedrazzoli, Paolo; Sapino, Anna; Semiglazov, Vladimir; Von Minckwitz, Gunter; Simoncini, EDDA LUCIA; Jacobs, Michael A.; Barry, Peter; Kühn, Thorsten; Darby, Sarah; Hermelink, Kerstin; Symmans, Fraser; Gennari, Alessandra; Schiavon, Gaia; Dogliotti, Luigi; Berruti, Alfredo; Bottini, Alberto
LHRH analogs in treatment of metastatic breast carcinoma
1987-01-01 Dogliotti, Luigi; Faggiuolo, R.; Berruti, Alfredo
Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer
2009-01-01 Generali, Daniele; Buffa, Francesca M.; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Papotti, Mauro; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B.
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]
2003-01-01 Atkins, Carl D; Rosenthal, Mark; Berruti, Alfredo; Tucci, Marcello; Terrone, Carlo; Scarpa, Roberto Mario; Angeli, Alberto; Dogliotti, Luigi; Saad, Fred; Gleason, Donald M.; Murray, Robin; Goas, J. Allen; Chen, Bee
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (fGF23)-independent mechanism
2011-01-01 Bellini, E.; Pia, A.; Brizzi, M. P.; Tampellini, M.; Torta, M.; Terzolo, M.; Dogliotti, Luigi; Berruti, Alfredo
The prognostic role of immunohistochemical chromogranin A expressionin prostate cancer patients is significantly modified by androgen-deprivation therapy
2010-01-01 Berruti, Alfredo; Bollito, Enrico; Cracco, Cecilia M.; Volante, Marco; Ciccone, Giovannino; Porpiglia, Francesco; Papotti, Mauro; Scarpa, Roberto Mario; Dogliotti, Luigi
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
2011-01-01 Fox, Stephen B; Generali, Daniele; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Mele, Teresa; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors
2008-01-01 Ceppi, Paolo; Volante, Marco; Ferrero, Anna; Righi, Luisella; Rapa, Ida; Rosas, Rosj; Berruti, Alfredo; Dogliotti, Luigi; Scagliotti, Giorgio V.; Papotti, Mauro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients | 1-gen-2010 | Mele, Teresa; Generali, Daniele; Fox, Stephen; Brizzi, Maria Pia; Bersiga, Alessandra; Milani, Manuela; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Volante, Marco; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian; Berruti, Alfredo | |
| Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network | 1-gen-2009 | Brizzi, Maria P.; Berruti, Alfredo; Ferrero, Anna; Milanesi, Enrica; Volante, Marco; Castiglione, Federico; Birocco, Nadia; Bombaci, Sebastiano; Perroni, Davide; Ferretti, Benedetta; Alabiso, Oscar; Ciuffreda, Libero; Bertetto, Oscar; Papotti, Mauro; Dogliotti, Luigi | |
| Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] | 1-gen-2016 | Arpino, Grazia; Generali, Daniele; Sapino, Anna; Del Mastro, Lucia; Frassoldati, Antonio; de Laurentiis, Michelino; Pronzato, Paolo; Mustacchi, Giorgio; Cazzaniga, Marina; De Placido, Sabino; Conte, Pierfranco; Cappelletti, Mariarosa; Zanoni, Vanessa; Antonelli, Andrea; Martinotti, Mario; Puglisi, Fabio; Berruti, Alfredo; Bottini, Alberto; Dogliotti, Luigi | |
| International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) | 1-gen-2015 | Amoroso, Vito; Generali, Daniele; Buchholz, Thomas; Cristofanilli, Massimo; Pedersini, Rebecca; Curigliano, Giuseppe; Daidone, Maria Grazia; Di Cosimo, Serena; Dowsett, Mitchell; Fox, Stephen; Harris, Adrian L.; Makris, Andreas; Vassalli, Lucia; Ravelli, Andrea; Cappelletti, Maria Rosa; Hatzis, Christos; Hudis, Clifford A.; Pedrazzoli, Paolo; Sapino, Anna; Semiglazov, Vladimir; Von Minckwitz, Gunter; Simoncini, EDDA LUCIA; Jacobs, Michael A.; Barry, Peter; Kühn, Thorsten; Darby, Sarah; Hermelink, Kerstin; Symmans, Fraser; Gennari, Alessandra; Schiavon, Gaia; Dogliotti, Luigi; Berruti, Alfredo; Bottini, Alberto | |
| LHRH analogs in treatment of metastatic breast carcinoma | 1-gen-1987 | Dogliotti, Luigi; Faggiuolo, R.; Berruti, Alfredo | |
| Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer | 1-gen-2009 | Generali, Daniele; Buffa, Francesca M.; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Papotti, Mauro; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B. | |
| Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2] | 1-gen-2003 | Atkins, Carl D; Rosenthal, Mark; Berruti, Alfredo; Tucci, Marcello; Terrone, Carlo; Scarpa, Roberto Mario; Angeli, Alberto; Dogliotti, Luigi; Saad, Fred; Gleason, Donald M.; Murray, Robin; Goas, J. Allen; Chen, Bee | |
| Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (fGF23)-independent mechanism | 1-gen-2011 | Bellini, E.; Pia, A.; Brizzi, M. P.; Tampellini, M.; Torta, M.; Terzolo, M.; Dogliotti, Luigi; Berruti, Alfredo | |
| The prognostic role of immunohistochemical chromogranin A expressionin prostate cancer patients is significantly modified by androgen-deprivation therapy | 1-gen-2010 | Berruti, Alfredo; Bollito, Enrico; Cracco, Cecilia M.; Volante, Marco; Ciccone, Giovannino; Porpiglia, Francesco; Papotti, Mauro; Scarpa, Roberto Mario; Dogliotti, Luigi | |
| The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen | 1-gen-2011 | Fox, Stephen B; Generali, Daniele; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Mele, Teresa; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L. | |
| Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors | 1-gen-2008 | Ceppi, Paolo; Volante, Marco; Ferrero, Anna; Righi, Luisella; Rapa, Ida; Rosas, Rosj; Berruti, Alfredo; Dogliotti, Luigi; Scagliotti, Giorgio V.; Papotti, Mauro |